US EditionPublished • loading... • Updated
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) VP Sells 2,265 Shares of Stock
Summary by insidertrades.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) VP Sells 2,265 Shares of Stock
PTC Therapeutics, Inc. (NASDAQ:PTCT - Get Free Report) VP Mark Elliott Boulding sold 2,265 shares of the stock in a transaction that occurred on Monday, April 6th. The shares were sold at an average price of $69.45, for a total transaction of $157,304.25. Following the sale, the vice president owned 105,212 shares in the company, valued at approximately $7,306,973.40. The trade was a 2.11% decrease in their position. The transaction was disclose…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
